We recently reported the first-in-human application of 68Ga-radiolabeled 2Rs15d sdAb for the assessment of HER2 expression in breast carcinoma and the same compound is now under investigation for the detection of HER2pos brain metastatic lesions [14,15]. The gene discussed is ERBB2; the disease is breast carcinoma.